Concord Biotech Announces 41st AGM on July 31, 2026

Concord Biotech Ltd has announced its 41st Annual General Meeting (AGM) will be held on Friday, July 31, 2026, at 12:00 Noon via Video Conferencing (VC) or Other Audio-Visual Means (OAVM). The meeting will address ordinary business including the adoption of audited standalone and consolidated financial statements for FY 2025-26, declaration of a dividend of ₹7.55 per equity share (755%), and the re-appointment of Mr. Ankur Vaid as a director. Special business includes the appointment of Mrs. Ekta Gupta as an Independent Director. The cut-off date for voting rights and dividend entitlement is fixed as Friday, July 24, 2026.